Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis: A Multicenter, Double-blind, Placebo-Controlled, Randomized Trial
Latest Information Update: 25 Apr 2019
Price :
$35 *
At a glance
- Drugs Atorvastatin (Primary)
- Indications Carotid stenosis; Nasopharyngeal cancer
- Focus Therapeutic Use
- 01 Dec 2017 Status changed from recruiting to suspended.
- 07 Feb 2014 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrial.gov record
- 27 Jan 2014 New trial record